| Detected | Trial | Change |
|---|---|---|
| 2026-05-15 | NCT05566795 DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma… |
overall status: "Recruiting" → "Active Not Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05566795 | DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma… | Low-grade Glioma | Active, Not Recruiting |
| Phase 2 | |||
| NCT05465174 | Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults | Craniopharyngioma, Child | Recruiting |
| NCT05828069 | A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or… | Recurrent Langerhans Cell Histiocytosis | Recruiting |
| NCT07206849 | Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06965114 | Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients… | Hairy Cell Leukemia | Recruiting |
| Phase 1 | |||
| NCT07441707 | A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults… | Low-grade Glioma | Recruiting |